Weight-Based Vancomycin Loading in Severe Obesity
A single patient, in septic shock from MRSA bacteremia. The disagreement is whether a large actual-body-weight loading dose is the right way to reach target concentration fast, or whether a hydrophilic drug's own distribution argues against scaling it to his full weight.
Byron O., a 44-year-old man, has driven for a rideshare app nearly full-time for the past four years, a job he took after a back injury made his previous warehouse work impossible, and he came to the emergency department after his left lower leg — red, swollen, and increasingly painful over three days — left him unable to work a shift or, by the second day, walk to his own bathroom without help. He arrived hypotensive, tachycardic, and febrile, meeting criteria for septic shock from what exam and imaging confirmed as extensive cellulitis with an underlying area of fluctuance; blood cultures drawn on arrival later grew methicillin-resistant Staphylococcus aureus. At 5'9" and 325 pounds, his BMI is 48, and the team's first concrete decision — before source control, before any question of duration — was how to dose the vancomycin loading dose meant to get him to target exposure as fast as possible in a patient this sick.
The 2020 ASHP/IDSA/PIDS/SIDP vancomycin therapeutic monitoring guidelines (Rybak et al., American Journal of Health-System Pharmacy, 2020) carry a separate, lower recommendation for obese adults than for everyone else: 20 to 25 mg/kg on actual body weight, with an explicit ceiling of 3000 mg per dose, rather than the 25 to 30 mg/kg quoted for critically ill patients generally. That distinction is not academic at Byron's size. Twenty-five milligrams per kilogram of his 147 kilograms is 3675 mg and thirty is 4410 mg, so the ceiling binds before the weight-based arithmetic ever finishes — and the 3000 mg he can actually receive works out to 20.4 mg/kg, the very bottom of the band the guideline wrote for him. The pharmacologic reason for both the lower band and the cap is that vancomycin is hydrophilic: it distributes mainly into lean tissue and extracellular fluid rather than adipose tissue, so its volume of distribution doesn't rise in direct proportion to total body weight the way a lipophilic drug's would. His only home medication is an occasional over-the-counter NSAID for the back injury that ended his warehouse career, and his admission creatinine of 1.0, unremarkable on its own, will matter more once the team starts thinking about sustained vancomycin exposure in a kidney that has never been stress-tested by an infection this severe.
In the emergency department, before the first dose
Give him the full 3000 mg — the maximum single loading dose the 2020 ASHP/IDSA guideline permits, and for him that is 20.4 mg/kg, the floor of the 20-to-25 mg/kg band that guideline writes specifically for obese adults. I want to be precise about what we are and aren't doing here: nobody is proposing 25 or 30 mg/kg on 147 kilograms, because 3675 and 4410 mg are both above a ceiling the guideline states outright. The argument is for going to that ceiling rather than stopping short of it, since the loading dose's job is rapid target attainment in septic shock, and anything under 3000 mg leaves him below the guideline's own obese-adult band. This is a one-time dose, not the maintenance strategy — the sustained-exposure conversation belongs downstream of it.
I don't dispute that 3000 mg is the ceiling — my question is whether the ceiling is also the target. The guideline lowered the obese band to 20 to 25 mg/kg for a reason: vancomycin is hydrophilic, its volume of distribution doesn't rise linearly with total weight, and the same document flags obese patients as being at higher risk of vancomycin-associated kidney injury and tells us to monitor them earlier and more intensively than anyone else. Going straight to the maximum permitted dose in the patient population the guideline singled out for caution reads to me like treating a cap as a recommendation. I'd give somewhat less than 3000 mg and get a level early, rather than start him at the top of what's allowed.
I'd give the 3000 mg — but I think the nephrologist has identified the right worry and attached it to the wrong dose. A single front-loaded exposure in a patient with this degree of shock is exactly what the target-attainment argument is built for, and 20.4 mg/kg is not an aggressive number by the guideline's own obese-adult band; it's the bottom of it.
Where the nephrotoxicity concern actually bites is maintenance, and the guideline says so directly — it caps most obese patients near 4500 mg per day and asks for early, frequent AUC monitoring. So: the very first maintenance dose should be AUC-guided on his actual renal function, not continued weight-based dosing into steady state. The loading dose and the maintenance strategy don't have to use the same logic, and treating them as one continuous weight-based approach is where the real risk sits.
Agreed within the hour: a 3000 mg loading dose — the guideline's stated maximum, and 20.4 mg/kg for him — given once, with maintenance dosing shifted immediately to AUC-guided calculation rather than continued weight-based dosing.
Not agreed: whether a stated ceiling should be treated as the default dose in the one population the same guideline flags for higher nephrotoxicity risk, or whether septic shock makes the top of the permitted range the right starting point — the nephrologist would have gone under 3000 mg and remains the most cautious of the three, and nobody resolved whether this reasoning extends to other hydrophilic antimicrobials without separately checking each drug's own volume-of-distribution behavior.